FISKE PLC

Share Issue/Capital Change • Aug 31, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4528Z

Fiske PLC

31 August 2018

31 August 2018

Fiske Plc

('Fiske' or 'the Company')

Issue of Equity

Fiske today announces that further to the acquisition of Fieldings Investment Management Ltd ("Fieldings") announced on 17 July 2017, the first deferred consideration payment due to the vendors of Fieldings will be £233,872.72 (the "First Deferred Consideration"). In accordance with the agreement, 20 per cent. of the First Deferred Consideration is payable in ordinary shares of 25p each in the Company ("Ordinary Shares") issued at the average closing price of the 11 days prior to allotment. The Company has therefore issued 57,392 Ordinary Shares at a price of 81.5p each.

Application has been made for these new Ordinary Shares to be admitted to trading on AIM with admission expected to take place on, or around, 6 September 2018.

Following admission, the Company's enlarged share capital will comprise 11,617,597 Ordinary Shares.  No shares are held in Treasury. Therefore, the total number of Ordinary Shares with voting rights is 11,617,597.  This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For further information please contact:

Samantha Harrison, Harrison Clarke, Samuel Rowe - Grant Thornton UK LLP (Nominated Adviser)

(tel: 020 7383 5100)

Gerard Luchini, Fiske Plc - Compliance Officer

(tel: 020 7448 4700)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

IOELLFLVTTILVIT